Mirova Us LLC Gilead Sciences, Inc. Transaction History

Mirova Us LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $26.6 Million - $30.3 Million	-469,932 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $7.5 Million - $9.43 Million	120,740 Added 34.58%	469,932 $29.7 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $4.35 Million - $5.05 Million	60,118 Added 20.8%	349,192 $26.9 Million
Q1 2020 May 13, 2020	SELL	$62.63 - $80.22 $1.63 Million - $2.08 Million	-25,966 Reduced 8.24%	289,074 $21.6 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $19.4 Million - $21.4 Million	315,040 New	315,040 $20.5 Million

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Mirova Us LLC, based on Form 13F filings with the SEC.

Stay updated on Mirova Us LLC with notifications on news.